Urgent ® PC Clinical Data
There are numerous publications highlighting the use of percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder, urinary urgency, urinary frequency and urge incontinence.
The Urgent PC Neuromodulation System is the only FDA-cleared system available to provide PTNS treatment. The device technology and treatment protocol are founded on the SANS device (Stoller's Afferent Nerve Stimulator).
Uroplasty recently commissioned a meta-analysis of studies highlighting the use of PTNS for the treatment of urinary urgency, urinary frequency and urge incontinence. Results of the analysis indicated that the majority of patients responded to PTNS (71%). Reductions in the number of voids, void volume and voids per night were highly significant.
The following abstracts are listed by publication year with the most recent listed first.
Click on the article title to view the full abstract:
Posterior tibial nerve stimulation in patients who have failed anticholinergic therapy: efficacy and time to response.
Leong, F., McLennan, M.T., Barr, S.A., & Steele, A.C. (2011) Female Pelvic Med Reconstr Surg 17:2, 74-75
Leong, F., McLennan, M.T., Barr, S.A., & Steele, A.C. (2011) Female Pelvic Med Reconstr Surg 17:2, 74-75
Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial.
Finazzi-Agrò, E., et al. (2010). J Urol, 184, 2001-2006.
Finazzi-Agrò, E., et al. (2010). J Urol, 184, 2001-2006.
Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT Trial.
Peters, K.M., et al. (2010). J Urol, 183, 1438-1443.
Peters, K.M., et al. (2010). J Urol, 183, 1438-1443.
Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.
MacDiarmid, S.A. et al. (2010). J Urol, 183, 234-240.
MacDiarmid, S.A. et al. (2010). J Urol, 183, 234-240.
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: Results from the Overactive Bladder Innovative Therapy Trial.
Peters, K.M. (2009). J Urol, 182, 1055-1061.
Peters, K.M. (2009). J Urol, 182, 1055-1061.
Percutaneous tibial nerve stimulation in the management of overactive bladder: a systematic review and meta-analysis.
Ruan, J., Dahabreh, I., Ip, S., Ferzandi, T., Wong, J. (2011). Female Pelvic Med & Reconstr Surg 17:5 supplement 2.
Ruan, J., Dahabreh, I., Ip, S., Ferzandi, T., Wong, J. (2011). Female Pelvic Med & Reconstr Surg 17:5 supplement 2.
Reduction in urge incontinence: symptom evaluation of percutaneous tibial nerve stimulation vs. sham trial
Peters, K., Carrico, D., Perez, R., Khan, A. (2011). Poster, North Central Section of the American Urology Association Meeting, Rancho Mirage, CA
Peters, K., Carrico, D., Perez, R., Khan, A. (2011). Poster, North Central Section of the American Urology Association Meeting, Rancho Mirage, CA
Long term treatment interval frequency of percutaneous tibial nerve stimulation: 18-month results from the STEP Study
Wooldridge, L., Carrico, D., MacDiarmid, S., Peters, K. (2011). Poster, SUNA Annual Meeting, San Antonio, TX.
Wooldridge, L., Carrico, D., MacDiarmid, S., Peters, K. (2011). Poster, SUNA Annual Meeting, San Antonio, TX.
Treatment interval frequency of percutaneous tibial nerve stimulation (PTNS): 18-month results from the STEP Study.
Peters, K., Carrico, D., Wooldridge, L. (2011) International Continence Society (ICS) Annual Meeting, Glasgow, UK
Peters, K., Carrico, D., Wooldridge, L. (2011) International Continence Society (ICS) Annual Meeting, Glasgow, UK
SUmiT Trial Outcomes: Clinical Insights Into Percutaneous Tibial Nerve Stimulation.
Sand, P., Peters, K., Carrico, D. (2011) International Continence Society (ICS) Annual Meeting, Glasgow, UK
Sand, P., Peters, K., Carrico, D. (2011) International Continence Society (ICS) Annual Meeting, Glasgow, UK
Treatment interval frequency of percutaneous tibial nerve stimulation (PTNS): preliminary results from the STEP Study.
MacDiarmid, S., Peters, K., Carrico, D., & Wooldridge, L. (2011). Poster, American Urology Association Annual Meeting , Washington, DC.
MacDiarmid, S., Peters, K., Carrico, D., & Wooldridge, L. (2011). Poster, American Urology Association Annual Meeting , Washington, DC.
Insight into percutaneous tibial nerve stimulation: critical evaluation of the SUmiT Trial.
Peters, K., Carrico, D., MacDiarmid, S., & Wooldridge, L. (2011). Poster, American Urology Association Annual Meeting, Washington, DC.
Peters, K., Carrico, D., MacDiarmid, S., & Wooldridge, L. (2011). Poster, American Urology Association Annual Meeting, Washington, DC.
Percutaneous tibial nerve stimulation vs. validated sham in those exposed to pharmacologic therapy.
Elser, D., & McCoy, C. (2011). Presentation, American College of Obstetricians and Gynecologists Annual Clinical Meeting, Washington, DC.
Elser, D., & McCoy, C. (2011). Presentation, American College of Obstetricians and Gynecologists Annual Clinical Meeting, Washington, DC.
Neuromodulation for the masses.
MacDiarmid, S. (2011) Presentation, Society for Urodynamics and Female Urology 2011 Winter Meeting, Phoenix, Arizona.
MacDiarmid, S. (2011) Presentation, Society for Urodynamics and Female Urology 2011 Winter Meeting, Phoenix, Arizona.
12 month percutaneous tibial nerve stimulation treatment interval results: outcomes from the OrBIT Trial.
MacDiarmid, S., et al. (2010). Poster, International Continence Society, Toronto, Canada.
MacDiarmid, S., et al. (2010). Poster, International Continence Society, Toronto, Canada.
12 week results from the SUmiT Trial: percutaneous tibial nerve stimulation vs validated sham in those exposed to pharmacologic therapy.
Peters, K., et al. (2010). Poster, International Continence Society, Toronto, Canada.
Peters, K., et al. (2010). Poster, International Continence Society, Toronto, Canada.
Comparative effectiveness: percutaneous tibial nerve stimulation (PTNS) and sacral nerve stimulation (SNS) for overactive bladder (OAB) treatment.
MacDiarmid, S.A. et al. (2010). Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.
MacDiarmid, S.A. et al. (2010). Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.
Percutaneous tibial nerve stimulation for the treatment of overactive bladder: treatment interval frequency.
MacDiarmid, S.A., et al. (2010). Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.
MacDiarmid, S.A., et al. (2010). Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.
New efficacy data on percutaneous tibial nerve stimulation: a multi-center, randomized, sham-controlled trial for overactive bladder syndrome.
Peters, K.M., et al. (2010). Presentation, Society for Urodynamics and Female Urology, St. Petersburg, FL.
Peters, K.M., et al. (2010). Presentation, Society for Urodynamics and Female Urology, St. Petersburg, FL.
6 and 12 month results from OrBIT trial comparing percutaneous tibial nerve stimulation (PTNS) vs. extended-release tolterodine.
Peters, K., et al. (2009). Poster, International Continence Society, San Francisco, CA.
Peters, K., et al. (2009). Poster, International Continence Society, San Francisco, CA.
Percutaneous tibial nerve stimulation: Efficacy with patients also taking anticholinergics.
Wooldridge, L. (2009). Poster, International Continence Society, San Francisco, CA.
Wooldridge, L. (2009). Poster, International Continence Society, San Francisco, CA.
Percutaneous tibial nerve stimulation for the treatment of urinary frequency, urinary urgency and urge incontinence: Results from a community-based clinic.
Wooldridge, L.S. (2009). Urologic Nursing, 29(3), 177-185.
Wooldridge, L.S. (2009). Urologic Nursing, 29(3), 177-185.
Percutaneous tibial nerve stimulation (PTNS): A literature-based assessment.
MacDiarmid, S.A., et al. (2009). Current Bladder Dysfunction Reports, 4, 29-33.
MacDiarmid, S.A., et al. (2009). Current Bladder Dysfunction Reports, 4, 29-33.
Long term sustained therapeutic effect of percutaneous tibial nerve stimulation in the management of Overactive Bladder.
MacDiarmid, S.A., et al. (2009). Presentation, American Urological Association Annual Meeting, Chicago, IL.
MacDiarmid, S.A., et al. (2009). Presentation, American Urological Association Annual Meeting, Chicago, IL.
A randomized multicenter study comparing percutaneous tibial nerve stimulation with pharmaceutical therapy for the treatment of overactive bladder.
Peters, K.M., et al. (2008). Presentation, Late Breaking Science Forum, American Urological Association Annual Meeting, Orlando, FL.
Peters, K.M., et al. (2008). Presentation, Late Breaking Science Forum, American Urological Association Annual Meeting, Orlando, FL.
Prospective randomized study for long term efficacy of percutaneous tibial nerve stimulation (PTNS) in patients with over active bladder: Maintenance protocol.
Farahat, Y.A. (2007). Abstract, 4th Pan Arab Continence Society Congress, Qatar.
Farahat, Y.A. (2007). Abstract, 4th Pan Arab Continence Society Congress, Qatar.
Who are the best candidates to be treated with percutaneous tibial nerve stimulation (PTNS)? A retrospective analysis of responder rate in different patient populations.
Finazzi-Agrò, E., et al. (2007). European Urology Supplement, 6(2),141.
Finazzi-Agrò, E., et al. (2007). European Urology Supplement, 6(2),141.
Peripheral tibial neurostimulation (PTNS) versus tolterodine in the treatment of women with urge urinary incontinence and urge symptoms.
Preyer, O., et al. (2007). Intern Urogynecol J: Suppl 1.
Preyer, O., et al. (2007). Intern Urogynecol J: Suppl 1.
Percutaneous tibial nerve stimulation: The Urgent PC device.
van Balkan, M.R. (2007). Expert Rev Med Devices, 4(5), 693-698.
van Balkan, M.R. (2007). Expert Rev Med Devices, 4(5), 693-698.
Percutaneous tibial nerve stimulation (PTNS): Results at long-term follow-up.
Cappellano, F., et al. (2006). Poster, SIUD National Congress, Italy.
Cappellano, F., et al. (2006). Poster, SIUD National Congress, Italy.
Posterior tibial nerve stimulation (PTNS) in the treatment of LUTS secondary to Parkinson's Disease.
Finazzi-Agrò, E., et al. (2006). Poster, SUID National Congress, Italy.
Finazzi-Agrò, E., et al. (2006). Poster, SUID National Congress, Italy.
Correlation between quality of life and voiding variables in patients treated with percutaneous tibial nerve stimulation.
van der Pal, F., et al. (2006). BJU Intl, 97(1), 113-116.
van der Pal, F., et al. (2006). BJU Intl, 97(1), 113-116.
Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: Is maintenance treatment necessary?
van der Pal, F., et al. (2006). BJU Intl, 97(3) , 547-550.
van der Pal, F., et al. (2006). BJU Intl, 97(3) , 547-550.
Prognostic factors for successful percutaneous tibial nerve stimulation.
van Balken, M.R., et al. (2006). Eur Urol, 49(2), 360-365.
van Balken, M.R., et al. (2006). Eur Urol, 49(2), 360-365.
Percutaneous tibial nerve stimulation (PTNS) in the treatment of urge incontinence: A double blind placebo controlled study.
Finazzi-Agrò, E. et al. (2005). Poster, SIUD National Congress, Italy.
Finazzi-Agrò, E. et al. (2005). Poster, SIUD National Congress, Italy.
Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms.
Ruiz, B.C., et al. (2004). Eur Urol, 45(1), 65-69.
Ruiz, B.C., et al. (2004). Eur Urol, 45(1), 65-69.
Posterior tibial nerve stimulation in the treatment of voiding dysfunction: Urodynamic data.
Vandoninck, V., et al. (2004). Neuro Urodyn, 23, 246-251.
Vandoninck, V., et al. (2004). Neuro Urodyn, 23, 246-251.
Percutaneous tibial nerve stimulation in the treatment of overactive bladder: Urodynamic data.
Vandoninck, V., et al. (2003). Neuro Urodyn, 22, 227-232.
Vandoninck, V., et al. (2003). Neuro Urodyn, 22, 227-232.
Posterior tibial nerve stimulation in the treatment of urge incontinence.
Vandoninck, V., et al. (2003). Neuro Urodyn, 22, 17-23.
Vandoninck, V., et al. (2003). Neuro Urodyn, 22, 17-23.
Temporary sacral and tibial neuromodulation in treating patients with overactive urinary bladder.
Mazo, E.B., & Krivoborodov, G.G. (2002). Zurnal Voprosy Nejrochirurgii Imeni NN Burdenko, 1, 17-21.
Mazo, E.B., & Krivoborodov, G.G. (2002). Zurnal Voprosy Nejrochirurgii Imeni NN Burdenko, 1, 17-21.
The efficacy of Stoller Afferent Nerve Stimulation in frequency/urgency syndrome: A randomised control trial.
Vohra, A.K., et al. (2002). Abstract 217, ICS 32nd Annual Meeting, Heidelberg.
Vohra, A.K., et al. (2002). Abstract 217, ICS 32nd Annual Meeting, Heidelberg.
Percutaneous afferent neuromodulation for the refractory overactive bladder: Results of a multicenter study.
Govier, F.E., et al. (2001). J Urol, 165, 1193-1198.
Govier, F.E., et al. (2001). J Urol, 165, 1193-1198.
Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction.
van Balken, M.R., et al. (2001). J Urol, 166(3), 914-918.
van Balken, M.R., et al. (2001). J Urol, 166(3), 914-918.
Use of peripheral neuromodulation of the S3 region for a treatment of detrusor overactivity: A urodynamic-based study.
Klingler, H.C., et al. (2000). Urol, 56, 766-771.
Klingler, H.C., et al. (2000). Urol, 56, 766-771.
Afferent nerve stimulation for pelvic floor dysfunction.
Stoller, M.L. (1999). Eur Urol, 35 (suppl 2), 16.
Stoller, M.L. (1999). Eur Urol, 35 (suppl 2), 16.
